Ann: FirstFlow Burette market update , page-10

That's right Risdon.

Von, comparing apples with oranges.

It is wrong to try to play one off against the other as being better or worse because of a shared interest in one product and based on their interest in that product.

MLA is not a one trick pony. The burette is only one small part of what MLA do. The animal stem cell arena is massive too and they are leading the way. Watch this space.

I am a holder of MLA - I am as biased as you are :-) Both companies have their merits and both can make big money, but both are still some way off realising this, which is why they are currently both worth peanuts.